ERBB2 and triple-negative breast carcinoma: After subdividing patients into Luminal A/B, HER2-enriched and triple negative breast cancer (TNBC) subgroups based on ER, PR and HER2 status, we found that this correlation was especially strong in HER2-enriched patients compared with other subtypes.